Format

Send to

Choose Destination
Emerg Med J. 2012 Nov;29(11):928-9. doi: 10.1136/emermed-2011-200013. Epub 2011 Aug 25.

Remifentanil use in emergency department patients: initial experience.

Author information

1
Department of Emergency Medicine, Our Lady of Lourdes Medical Center, 1600 Haddon Avenue, Camden, NJ 08103, USA. sacchetti1011@gmail.com

Abstract

INTRODUCTION:

This study examines the use of remifentanil, an ultra-short-acting opioid, in emergency department (ED) patients.

METHODS:

Chart review of ED patients receiving remifentanil for procedural sedation in an urban general ED.

RESULTS:

50 patients over a 28-month period with a mean age of 30.6 years (±2.6) were reviewed. Procedures performed included: abscess drainage (13); fracture care (9); thoracostomy (8); lumbar puncture (7); shoulder reduction (3); cardioversion (3) and others (7). Six (12%) cases received additional rescue medications. All procedures were successfully completed in the ED. No complications were recorded but 21 (42%) were admitted for underlying pathology.

CONCLUSION:

Remifentanil is a safe and effective medication for ED use.

PMID:
21873319
DOI:
10.1136/emermed-2011-200013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center